Health Canada approves new indication for Merck's Prevymis for prevention of CMV disease in high─risk adult kidney ...
Merck, known as MSD outside of the United States and Canada, announced that Health Canada has approved a new indication for Prevymis (letermovir) for the prophylaxis of cytomegalovirus (CMV) disease in adult kidney transplant recipients at high risk ( …